Virtual West Oncology Conference
2021 Advanced NSCLC Targeted Therapy Updates: Efficacy & Safety Profile of Larotrectinib & Entrectinib for NTRK Fusion, Dabrafenib+Trametinib Combo in BRAF Mutated Disease
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
Login to view comments.
Click here to Login